Welcome guest, Sign in

Home

X
加载中

Estimation of circulating immune complex in tuberculosis patients has shown better insight to the infection. Isolating circulating immune complex helps quantifying both antigen and antibody in the serum. It’s a simple procedure to improve the sensitivity and specificity in serodiagnosis of tuberculosis. This protocol may be modified to detect antigen/antibody in other infectious diseases.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Isolation of Circulating Immune Complexes from TB Patient Serum for Serodiagnosis

Immunology > Antibody analysis > Antibody detection
Authors: Uma Devi Ranganathan
Uma Devi RanganathanAffiliation: Department of Pediatrics (Infectious Diseases), Albert Einstein College of Medicine, Bronx, USA
For correspondence: krumadevi@gmail.com
Bio-protocol author page: a44
Ramalingam Bethunaickan
Ramalingam BethunaickanAffiliation: Department of Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, USA
Bio-protocol author page: a24
 and Alamelu Raja
Alamelu RajaAffiliation: Department of Immunology, Tuberculosis Research Center (ICMR), Chennai, India
Bio-protocol author page: a223
Vol 2, Iss 11, 6/5/2012, 5719 views, 0 Q&A, How to cite
DOI: https://doi.org/10.21769/BioProtoc.188

[Abstract] Estimation of circulating immune complex in tuberculosis patients has shown better insight to the infection. Isolating circulating immune complex helps quantifying both antigen and antibody in the serum. It’s a simple procedure to improve the sensitivity and specificity in serodiagnosis of tuberculosis. This protocol may be modified to detect antigen/antibody in other infectious diseases.

Keywords: Circulating Immune complex, Serodiagnosis, Tuberculosis, TB diagnosis, Antigen and antibody detection

Materials and Reagents

  1. Boric acid (Sigma-Aldrich, catalog number: B6768)
  2. Disodium tetraborate (Borax) (Sigma-Aldrich, catalog number: 71996)
  3. NaCI (Sigma-Aldrich, catalog number: S3014)
  4. Polyethylene glycol (PEG 8000) (Sigma-Aldrich, catalog number: 89510)
  5. Phosphate buffer saline (Life Technologies, Gibco®, catalog number: 20012-027)
  6. NaHCO3 (Sigma-Aldrich, catalog number: S6014)
  7. Na2CO3 (Sigma-Aldrich, catalog number: 330361)
  8. BSA (Sigma-Aldrich, catalog number: A7030)
  9. Tween 20 (Sigma-Aldrich, catalog number: P9416)
  10. Antihuman affinipure IgG/lgA/lgM HRP [The Jackson Laboratory, USA, catalog number: 709-036-149 (IgG); 109-036-011 (IgA); 309-036-043 (IgM)]
  11. Na2HPO4 (Sigma-Aldrich, catalog number: S3264)
  12. Citric acid (Sigma-Aldrich, catalog number: 251275)
  13. O-Phenylenediamine (OPD) (Sigma-Aldrich, catalog number: P5412)
  14. H2SO4 (Sigma-Aldrich, catalog number: 320501)
  15. 0.1 M borate buffer (pH 8.4) (see Recipes)
  16. 7% polyethylene glycol (PEG) (see Recipes)
  17. Phosphate buffer saline (PBS) (see Recipes)
  18. 0.06 M Carbonate buffer (pH 9.6) (see Recipes)
  19. Blocking solution (see Recipes)
  20. Primary antibody (see Recipes)
  21. Secondary antibody (see Recipes)
  22. Substrate buffer (see Recipes)
  23. Substrate (see Recipes)
  24. Stop solution (see Recipes)

Equipment

  1. Refrigerated bench-top centrifuges
  2. 96 wells flat bottom ELISA plates (Nunc®, catalog number: 44-2404-21)
  3. ELISA washer (Organon Teknika)
  4. Spectromax ELISA reader (Molecular Devices)

Procedure

  1. Circulating immune complex preparation
    1. Two hundred microliters of the test sera were centrifuged at 10,000 rpm for 5 min to remove any suspended particles.
    2. Next, 150 μl of the upper layer of the sera was collected and mixed with equal volume of 7% PEG. This gives a final concentration of 3.5% PEG in the sera.
    3. The sera were then vortexed and left overnight at 4 °C for precipiation of the immune complex.
    4. The next day, the precipitated immune complex was pelleted by centrifugation at 13,000 rpm for 10 min. The supernatant was discarded and the pellet was washed two times with 3.5% PEG.
    5. The circulating immune complex was finally dissolved in 0.01 M PBS and made up to the original volume of 150 μl.

  2. Enzyme linked immunosorbent assay
    1. Polystyrene ELISA plates (96 wells, Nunc Maxisorp, flat bottom) were coated with 5 μg/ml of CFA, 1 μg/ml for 38 and 30 kDa and 0.2 μg/ml for 16 kDa of purified mycobacterial antigen in Carbonate buffer (pH 9.6). The plates were incubated with antigen overnight at 4 °C.
      Note: Mycobacterial antigen is purified in the lab.
    2. The plates were washed four times with PBS buffer containing 0.1 % Tween 20 by the automatic ELISA washer.
    3. The non-specific sites in the wells were blocked with blocking solution for 1 h at 37 °C. After four washes with PBST, the plates were incubated for one hour at 37 °C with the precipitated circulating immune complex in 1/100 dilution. The plates were washed four times after 1 h incubation at 37 °C .The plates were then incubated with antihuman IgG peroxidase conjugate.
    4. At the end of 1 h of incubation at 37 °C and washing, the colour was developed by the addition of 100 μl of the substrate to each well.
    5. After arresting the reaction with 50 μl of 8 N H2SO4, the optical density was read in the Spectromax ELISA reader at 490 nm wavelength.
      Note: IgA and IgM antibody determination were also carried out among the same patients and healthy subjects. For this, Antihuman IgA and Antihuman IgM were used in the dilution of 1:500 and 1:1, 000 respectively.
    6. Antibody estimation for IgG, A and M isotypes were carried out for CIC precipitated patients and normal healthy serum. The ELISA positivity was calculated based on the OD values of the mean plus two standard deviation of the normal healthy serum. This value was used as the cut off value to decide the Elisa positivity of the unknown serum.

Notes

The samples to be assayed in a plate were randomly allocated to different wells within the plate and were also coded to conceal the identity of the specimens. In each of the experimental replicates of a positive reference serum (serum which has a strong positive response with high concentration of antibody from a smear microscopy confirmed tuberculous patient) was included. The mean value of the positive reference serum in independent experiments was taken as a constant reference value to assess plate-to-plate and day-to-day variations. Each plate had blank wells which represents the wells without antibody binding.

Recipes

  1. 0.1 M borate buffer (pH 8.4)
    0.1 M boric acid 6.184 g
    0.5 mM disodium tetraborate 9.5 g
    75 mM NaCI 4.4 g
    Made up to 1 L with distilled water
    The pH should be 8.4 without adjusting
  2. 7% PEG
    PEG 7 g
    Borate buffer 100 ml
  3. 3.5% PEG
    7% PEG 50 ml
    Borate buffer 50 ml
  4. Phosphate buffer saline (PBS)
    1. 0.25 M PBS (25x stock solution)
    2. 0.01 M PBS (1x buffer)
    Reagents a and b are prepared as mentioned in immunoblot section
  5. 0.06 M Carbonate buffer (pH 9.6)
    Solution A: [NaHCO3 (1 M)] 8.4 g/100 ml
    Solution B: [Na2CO3 (1 M)] 10.6 g/100 ml
    45.3 ml of A + 11 ml of B and made up to 1 L
  6. Blocking solution
    1 % BSA in PBS+0.1% Tween 20
  7. Primary antibody
    Circulating immune complex (CIC) 1:100 dilution
  8. Secondary antibody
    Antihuman affinipure IgG/lgA/lgM HRP
  9. Substrate buffer (phosphate citrate buffer)
    1. Solution A
      0.2 M Na2HPO4 8.517 g
      Milli Q water (to make up to) 300 ml
    2. Solution B
      0.1 M Citric acid 5.254 g
      Milli Q water (to make up to) 250 ml
    3. 257 ml of solution A and 243 ml of solution B were mixed with 500 ml of Milli Q water to give 1 L of phosphate citrate buffer (pH 5.0)
  10. Substrate
    OPD 10 mg (1 tablet)
    Dissolved in 25 ml of 0.05 M phosphate-citrate buffer (pH 5.0)
    30% H2O2 10 μl added to the above.
  11. Stop solution (8 N H2SO4)
    36 N H2SO4 222.2 ml
    Milli Q water (made upto) 1,000 ml

Acknowledgments

This protocol was adopted from previous work published by Raja et al. (1995). 

References

  1. Raja, A., Ranganathan, U. D. and Ramalingam, B. (2006). Clinical value of specific detection of immune complex-bound antibodies in pulmonary tuberculosis. Diagn Microbiol Infect Dis 56(3): 281-287.
  2. Raja, A., Narayanan, P. R., Mathew, R. and Prabhakar, R. (1995). Characterization of mycobacterial antigens and antibodies in circulating immune complexes from pulmonary tuberculosis. J Lab Clin Med 125(5): 581-587.
  3. Uma Devi, K. R., Ramalingam, B., Brennan, P. J., Narayanan, P. R. and Raja, A. (2001). Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38 kDa antigen in pulmonary tuberculosis. Tuberculosis (Edinb) 81(3): 249-253.


How to cite: Ranganathan, U. D., Bethunaickan, R. and Raja, A. (2012). Isolation of Circulating Immune Complexes from TB Patient Serum for Serodiagnosis. Bio-protocol 2(11): e188. DOI: 10.21769/BioProtoc.188; Full Text



Share Your Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
How to cite
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook